伴与不伴显著储尿期症状患者的前列腺激光剜除术结局
在三级医疗数据库中连续纳入2017年11月至2022年9月接受前列腺激光剜除术(LEP)的患者,比较储尿期症状阳性(IPSS储尿期评分>8)与阴性患者的下尿路症状恢复差异。291例中180例(62%)为储尿期症状阳性;阳性状态是术后1个月和3个月总IPSS更高及生活质量更差的危险因素,但12个月时两组无差异。
要点
- 储尿期症状阳性是LEP术后1个月和3个月总IPSS更高及生活质量更差的危险因素。
- 储尿期症状阳性与阴性患者术后12个月总IPSS、储尿期评分、排尿期评分及生活质量无差异。
- 作者认为储尿期症状阳性患者也可考虑LEP,并需在术后初期加强患者教育。
核心结论
- 储尿期症状阳性患者接受LEP后的长期获益似乎与储尿期症状阴性患者相似。
- 但显著储尿期症状与LEP术后1个月和3个月更高的总IPSS及更差的生活质量相关。
- 作者认为这些发现支持在储尿期症状阳性病例中也考虑LEP,并需在术后初期进行充分的患者教育。
研究设计与样本
- 在三级医疗数据库中连续识别2017年11月至2022年9月接受LEP的储尿期症状阳性(严重储尿期症状,国际前列腺症状评分[IPSS]储尿期评分>8)与储尿期症状阴性患者。
- 采用混合线性模型检验LEP术后1、3和12个月IPSS及生活质量的变化。
- 采用多元线性回归模型检验术后1、3和12个月下尿路症状及生活质量恢复的危险因素。
- 研究共纳入291例患者,其中180例(62%)为储尿期症状阳性。
主要发现
- 储尿期症状阳性与阴性患者LEP术后12个月的平均校正总IPSS、IPSS储尿期评分、IPSS排尿期评分及生活质量均无差异。
- 在多元线性回归模型中,储尿期症状阳性是LEP术后1个月总IPSS更高的危险因素(β系数2.98,P=0.004)。
- 储尿期症状阳性是LEP术后3个月总IPSS更高的危险因素(β系数2.24,P=0.04)。
- 储尿期症状阳性是LEP术后1个月生活质量更差的危险因素(β系数0.74,P=0.006)。
- 储尿期症状阳性是LEP术后3个月生活质量更差的危险因素(β系数0.73,P=0.004);术后12个月时储尿期症状阳性与阴性患者之间无差异。
临床怎么用
- 作者认为,这些发现支持在储尿期症状阳性病例中也考虑LEP。
- 作者认为,需要在LEP术后初期进行充分的患者教育。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To test for differences in recovery of lower urinary tract symptoms (LUTS) between patients with storage-positive vs -negative symptoms after laser enucleation of the prostate (LEP). PATIENTS AND METHODS: Consecutive storage-positive (severe storage symptoms, International Prostate Symptom Score [IPSS] storage subscore >8) vs storage-negative patients treated with LEP (November 2017-September 2022) within our tertiary-care database were identified. Mixed linear models tested for changes in IPSS and quality of life (QoL) at 1, 3 and 12 months after LEP. Multiple linear regression models tested for LUTS and QoL recovery risk factors at 1, 3 and 12 months. RESULTS: Of 291 study patients, 180 (62%) had storage-positive symptoms. There were no differences between storage-positive and -negative patients in mean adjusted total IPSS, IPSS-storage, IPSS-voiding and QoL at 12 months after LEP. In multiple linear regression models, storage-positive status was identified as a risk factor for higher IPSS at 1 month (β coefficient 2.98, P = 0.004) and 3 months (β coefficient 2.24, P = 0.04), as well as for more unfavourable QoL at 1 month (β coefficient 0.74, P = 0.006) and 3 months (β coefficient 0.73, P = 0.004) after LEP. Conversely, at 12 months there were no differences between storage-positive vs -negative patients. CONCLUSION: Storage-positive patients appear to experience similar long-term benefits from LEP compared to storage-negative patients. However, significant storage symptoms are associated with higher total IPSS and less favourable QoL at 1 and 3 months after LEP. These findings advocate for the consideration of LEP also in storage-positive cases with the need for thorough patient education especially in the initial post-LEP period.
引用
- Cano Garcia C, Welte M, Filzmayer M, et al. Outcomes after laser enucleation of the prostate with and without significant storage symptoms. BJU Int. 2024. PMID: 39113489. doi:10.1111/bju.16495
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。